Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
University of California, San Diego
Mercy Gilbert Medical Center at AZ
Chandler Regional Medical Center at Chandler AZ
UCI Medical Center
Information provided by (Responsible Party):
Stemedica Cell Technologies, Inc.
ClinicalTrials.gov Identifier:
NCT01297413
First received: February 10, 2011
Last updated: December 21, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)